Through univariate logistic regression models, we found that advanced age (≥65 years old), chronic comorbidities, lymphocytopenia, elevated hs‐CRP, increased D‐dimer, and elevated levels of ALT were the key risk factors for the progression of COVID‐19 patients into their severe stage (Table 3). This evidence concerns the gene GPT and lymphopenia.